Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 404-110-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
The toxicokinetic profile of a substance comprises its absorption into the body, its distribution in the body, its metabolism in the body and its excretion from the body. Taking into account the physicochemical properties and the toxicological test results, qualitative estimates for these aspects may be deduced for pigment additive RL.
Absorption: a prerequisite for a relevant absorption is that the substance can be dissolved in either aqueous (e.g., gastrointestinal fluid, blood plasma, sweat) or lipophilic (e.g., lipoproteins, lipid membranes, triglycerides) media or in both. Pigment additive RL can be considered to be insoluble in water and only slightly soluble in n-octanol or fat. Therefore, it is unlikely that relevant amounts of pigment additive RL become systemically bioavailable after oral, dermal or inhalation exposure.
The results of acute oral toxicity, acute dermal toxicity and repeated oral toxicity studies also give valuable indications with regard to absorption of the test substance.
Based on the acute oral toxicity and the 28-day oral toxicity studies, which did not reveal any systemic effects that would indicate that the pigment additive had entered the body, no indications of significant absorption via the gastrointestinal tract has to be assumed.
Pigment additive RL does not have particular skin or eye irritating or skin sensitizing properties that would imply a dermal absorptive potential.
In the unlikely event of exposure to aerosolized pigment additive in respirable form, the substance is considered likely to behave like an inert dust. Therefore, the deposited pigment additive particles will mostly be cleared from the lung via the mucocilliary transport. As pigment additive RL will not dissolve in the lung surfactant, the only way how pigment additive RL can enter the body is via phagocytosis of pigment additive RL particles by lung macrophages followed by migration of the macrophages into the interstitium and into the draining lymph nodes. However, the internal dose delivered via this mechanism can be considered negligible.
Distribution: the 28-day oral repeated dose toxicity study did not indicate any relevant histopathological changes in any of the investigated organs. This may indicate that either the pigment additive does not affect special organs as targets, i.e., is non-toxic, or is not distributed within the body in significant amounts. As indicated above, the physico-chemical parameters of the pigment additive support the conclusion that the pigment additive is not absorbed into the body and thus does not become systemically available. There were also no other signs of deposition of the pigment additive in any organ including excretory organs, like the kidney, indicating that even exposure to high doses of the pigment additive does not lead to bioaccumulation in special compartments of the body.
Metabolism: Since the dissolution of the substance in cellular fluid or cellular membranes is a prerequisite for its metabolism, it is unlikely that the scarcely soluble pigment additive becomes accessible for metabolizing systems in relevant amounts. The results of the mutagenicity tests provide useful indications for qualitative consideration of the metabolic fate of pigment additive RL. In the mutagenicity tests, the pigment additive proved to be non-toxic and non-mutagenic in the absence as well as in the presence of an exogenous metabolizing system, indicating that the pigment additive is not converted into toxic or genotoxic metabolites. This conclusion is also supported by the lack of any morphological and histopathological changes of organs involved in xenobiotic metabolism, such as the liver, in the repeated dose toxicity study.
Excretion: the available data indicate that pigment additive RL is not absorbed into the body. In line with this conclusion, the 28-day oral repeated dose toxicity study did not indicate morphological or histopathological effects of the pigment additive on organs involved in excretion of chemicals from the body, such as the kidney. There was no indication that the substance was present in the urine. Moreover, from the repeated oral toxicity studies, it can be concluded that, after oral exposure, the pigment additive is excreted unchanged via the faeces.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.